vimarsana.com
Home
Live Updates
MEDEXPRIM PARTNERS WITH CONTEXTFLOW TO INDICATE TREATMENT EFFECTIVENESS & PREDICT DISEASE PROGRESSION IN NSCLC : vimarsana.com
MEDEXPRIM PARTNERS WITH CONTEXTFLOW TO INDICATE TREATMENT EFFECTIVENESS & PREDICT DISEASE PROGRESSION IN NSCLC
The partnership is designed to improve observation of non-small cell lung cancer.
Related Keywords
Austria
,
Vienna
,
Wien
,
Canada
,
Anne Sophie Labeta
,
Romain Cazavan
,
Julie Sufana
,
Marcel Wassink
,
University Of Vienna
,
Technical University Of Vienna
,
Chief Commercial Officer Marcel Wassink
,
Chief Commercial Officer Marcel
,
Medexprim Suite
,
World Evidence
,
Medical University
,
Technical University
,
Support Lung Cancer
,
Medexprim
,
He European Leader In Multiomic Real World Datasets
,
Contextflow
,
He Viennese Based Medical Device Manufacturer
,
Advance Chest Ct
,
Detects
,
Quantifies
,
Nd Visualises Lung Nodules
,
vimarsana.com © 2020. All Rights Reserved.